Case Control Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 26, 2024; 12(21): 4469-4475
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4469
Efficacy of budesonide/formoterol inhalation powder in treating viral pneumonia in children
Zi-Liang Lin, Xu Xu, Jiao-Jiao Yang, Li-Qiang Lu, Heng Huang, Xiao-Zhen Hua, Li-Dang Lu
Zi-Liang Lin, Xu Xu, Jiao-Jiao Yang, Li-Qiang Lu, Heng Huang, Xiao-Zhen Hua, Li-Dang Lu, Department of Pediatrics, Cangnan Hospital Affiliated to Wenzhou Medical University, Wenzhou 325800, Zhejiang Province, China
Author contributions: Lin ZL designed the study and wrote the first draft; Xu X and Yang JJ completed methodology, data curation, and data analysis; Lu LQ, Huang H, and Hua XZ were responsible for the production of the images; Lu LD revised the paper; All authors have read and approve the final manuscript.
Supported by the Wenzhou Basic Medical and Health Science and Technology Project, No. Y20210307.
Institutional review board statement: The study protocols were approval by the Ethics Committee of Cangnan Hospital Affiliated to Wenzhou Medical University and performed in accordance with the Declaration of Helsinki.
Informed consent statement: All participants' guardian provided written informed consent to child enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: All data generated or analyzed during this study are included in this published article.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xu Xu, MD, Doctor, Department of Pediatrics, Cangnan Hospital Affiliated to Wenzhou Medical University, No. 2288 Yucang Road, Lingxi Town, Wenzhou 325800, Zhejiang Province, China. xuxu1984_05_05@163.com
Received: March 24, 2024
Revised: May 9, 2024
Accepted: May 21, 2024
Published online: July 26, 2024
Processing time: 99 Days and 3.5 Hours
Core Tip

Core tip: Treatment with budesonide/formoterol inhalation powder can significantly improve the efficacy of treatment of viral pneumonia in children. The mechanism of action may be related to downregulation of the inflammatory response and improvement of cellular immune function.